In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden.
about
Clinical applications of palifermin: amelioration of oral mucositis and other potential indicationsTLR4/PKC-mediated tight junction modulation: a clinical marker of chemotherapy-induced gut toxicity?Topical Recombinant Human Epidermal Growth Factor for Oral Mucositis Induced by Intensive Chemotherapy with Hematopoietic Stem Cell Transplantation: Final Analysis of a Randomized, Double-Blind, Placebo-Controlled, Phase 2 TrialA phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myelomaNew pharmacotherapy options for chemotherapy-induced alimentary mucositis.Management of Mucositis During Chemotherapy: From Pathophysiology to Pragmatic Therapeutics.Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma.Palifermin reduces infection rate and hyperfibrinogenemia in patients treated with high-dose chemotherapy based on beam or BU-thiothepa.Bismuth adjuvant ameliorates adverse effects of high-dose chemotherapy in patients with multiple myeloma and malignant lymphoma undergoing autologous stem cell transplantation: a randomised, double-blind, prospective pilot study.Impact of palifermin on incidence of oral mucositis and healthcare utilization in children undergoing autologous hematopoietic stem cell transplantation for malignant diseases.Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors.Impact of palifermin on intestinal mucositis of HSCT recipients after BEAM.Efficacy of palifermin on oral mucositis and acute GVHD after hematopoietic stem cell transplantation (HSCT) in hematology malignancy patients: a meta-analysis of trials.Burden of oral mucositis in stem cell transplant patients-the patients' perspective.Associations of High-Dose Melphalan Pharmacokinetics and Outcomes in the Setting of a Randomized Cryotherapy Trial.Cryotherapy reduces oral mucositis and febrile episodes in myeloma patients treated with high-dose melphalan and autologous stem cell transplant: a prospective, randomized study.
P2860
Q26852139-C0F46954-3294-44BA-8F7F-1AE243283503Q27015742-2D30F4E9-545E-42E8-A723-638DA7E72AEDQ36237979-AEDE89D6-C29E-43B3-9784-F5A7807B5508Q37700318-64F9A608-3DD7-4841-B268-0E5CBCEB1798Q38175515-744433A8-45DE-4B75-9A3A-C4D8F436042DQ38589005-EFCB604D-063C-44BF-926D-7289E42E0E00Q38797546-02F251A3-F635-47AE-AE73-E1BB7E988BEFQ40201079-EE2E0C89-70F7-42BF-8B05-4D6DAE41B2C3Q40410888-FD5E8EB1-6602-44FD-9B7A-A591CFE87774Q45302802-EC204CA4-7FC7-4A7E-8CB7-A7B7CB99E27BQ47404146-9236D40E-25DD-4799-AF8D-6B4036220B07Q47753506-288F66B9-456F-4936-B38F-567B4A3DD723Q49332936-CCD9348B-83C9-4380-A9BD-A333A6677B5EQ49344260-8419CBBE-D43A-40BB-900A-C9A3CDF6A88CQ50912223-C865CE35-D1AB-4E1C-B658-BA3B44399513Q53815007-713912F9-4710-4C77-95F3-7D0AE243D07C
P2860
In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient's burden.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
In a high-dose melphalan setti ...... s or related patient's burden.
@en
type
label
In a high-dose melphalan setti ...... s or related patient's burden.
@en
prefLabel
In a high-dose melphalan setti ...... s or related patient's burden.
@en
P2093
P2860
P356
P1476
In a high-dose melphalan setti ...... is or related patient's burden
@en
P2093
A Lissmats
CLWP of the EBMT
D Niederwieser
M de Château
N Blijlevens
P2860
P2888
P304
P356
10.1038/BMT.2012.257
P407
P577
2012-12-17T00:00:00Z
P6179
1010934268